Mon, Aug 16, 2021
Healthcare Services Sector Update – July 2021
The S&P Healthcare Services Index decreased by 3.1% over the last month, compared to the S&P 500 Index, which increased 1.7% over the same period.
Over the past month:
- The sectors that experienced the most growth were Acute Care Hospitals (up 17.2%), Contract Research Organizations (up 5.8%) and Distribution (up 5.5%).
- The sectors that experienced the largest decline were Providers – Other (down 24.3%), Telemedicine (down 10.8%) and Home Medical Equipment (down 9.2%).
- The current average Last Twelve Months (LTM) revenue and LTM EBITDA multiples for the healthcare services industry overall are 3.46x and 15.5x, respectively.
The sectors with the highest valuation multiples include:
- HCIT (4.59x LTM revenue, 25.9x LTM EBITDA)
- Contract Research Organizations (4.67x LTM revenue, 25.7x LTM EBITDA)
- Consumer Directed Health/Wellness (6.83x LTM revenue, 22.2x LTM EBITDA)
- Home Health/Hospice (2.70x LTM revenue, 22.0x LTM EBITDA)
Healthcare Investment Banking
Healthcare expertise for middle-market M&A transactions.
Mergers and Acquisitions (M&A) Advisory
Kroll’s investment banking practice has extensive experience in M&A deal strategy and structuring, capital raising, transaction advisory services and financial sponsor coverage.
Transaction Advisory Services
Kroll’s Transaction Advisory Services platform offers corporate and financial investors with deep accounting and technical expertise, commercial knowledge, industry insight and seamless analytical services throughout the deal continuum.
Fairness and Solvency Opinions
Duff & Phelps Opinions is a global leader in Fairness Opinions and Special Committee Advisory, ranking #1 for total number of U.S. and global fairness opinions over the past 10 years, according to Refinitiv cumulative data from 2013-2022.
Private Capital Markets – Debt Advisory
Kroll has extensive experience raising capital for middle-market companies to support a wide range of transactions.
Financial Sponsors Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.